KIIL HARRY SKIP 4

What Happened Harry "Skip" Kiil, EVP & President, Cardiovascular at Medtronic (MDT), reported two open‑market sales on June 8, 2026. He sold 3,961 shares at $80.44 ($318,623) and 228 shares at $80.45 ($18,343), for a total of 4,189 shares and proceeds of approximately $336,966. These were sales (S) reported on a Form 4.

Key Details

• Transaction date: 2026-06-08 (reported on Form 4 filed 2026-06-09)
• Prices: $80.44 (3,961 shares) and $80.45 (228 shares)
• Total shares sold: 4,189; total proceeds ≈ $336,966
• Transaction type/code: Open‑market sales (S)
• Shares owned after transaction: Not specified in the filing
• Footnotes/plan: Filing does not indicate a 10b5‑1 plan, tax withholding, or other special footnotes
• Timeliness: Form 4 was filed the next day and is not indicated as late

Context This report documents insider sales, which are often routine (e.g., diversification or liquidity) and do not by themselves signal a change in company fundamentals. For retail investors, purchases typically carry more direct informational weight than sales; here, the filing simply records the open‑market disposition of shares by an executive.